| 1. |
Maenz M, Schlüter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease[J]. Prog Retin Eye Res, 2014, 39: 77-106. DOI: 10.1016/j.preteyeres.2013.12.005.
|
| 2. |
钱门宝, 李石柱, 周晓农. 我国重要食源性寄生虫病的流行和控制[J]. 热带病与寄生虫学, 2021, 19(5): 241-244. DOI: 10.3969/j.issn.1672-2302.2021.05.001.Qian MB, Li SZ, Zhou XN. Epidemiological status and control of important food-borne parasitic diseases in China[J]. J Trop Dis Parasitol, 2021, 19(5): 241-244. DOI: 10.3969/j.issn.1672-2302.2021.05.001.
|
| 3. |
Holland GN. Ocular toxoplasmosis: a global reassessment[J]. Am J Ophthalmol, 2003, 136(6): 973-988. DOI: 10.1016/j.ajo.2003.09.040.
|
| 4. |
Smith JR, Ashander LM, Arruda SL, et al. Pathogenesis of ocular toxoplasmosis[J/OL]. Prog Retin Eye Res, 2021, 81: 100882[2020-07-24]. https://pubmed.ncbi.nlm.nih.gov/32717377/. DOI: 10.1016/j.preteyeres.2020.100882.
|
| 5. |
Miyagaki M, Zong Y, Yang M, et al. Ocular toxoplasmosis: advances in toxoplasma gondii biology, clinical manifestations, diagnostics, and therapy[J]. Pathogens, 2024, 13(10): 898. DOI: 10.3390/pathogens13100898.
|
| 6. |
陶勇. 眼内液病原学检测的研究进展[J]. 中华眼科杂志, 2018, 54(7): 551-556. DOI: 10.3760/cma.j.issn.0412-4081.2018.07.019.Tao Y. Research on examination of intraocular fluid for diagnosis of infectious ocular diseases[J]. Chin J Ophthalmol, 2018, 54(7): 551-556. DOI: 10.3760/cma.j.issn.0412-4081.2018.07.019.
|
| 7. |
Garweg JG, Pleyer U. Treatment strategy in human ocular toxoplasmosis: why antibiotics have failed[J/OL]. J Clin Med, 2021, 10(5): 1090[2021-03-05]. https://pubmed.ncbi.nlm.nih.gov/33807871/. DOI: 10.3390/jcm10051090.
|
| 8. |
邱燕华, 董朕, 张吉丽, 等. 弓形虫病的治疗研究进展[J]. 中国动物传染病学报, 2023, 31(4): 213-222.Qiu YH, Dong Z, Zhagn JL, et al. Advances in the treatment of toxoplasmosis[J]. Chinese Journal of Animal Infectious Diseases, 2023, 31(4): 213-222.
|
| 9. |
Dunay IR, Gajurel K, Dhakal R, et al. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice[J/OL]. Clin Microbiol Rev, 2018, 31(4): e57-e67[2018-09-12]. https://pubmed.ncbi.nlm.nih.gov/30209035/. DOI: 10.1128/CMR.00057-17.
|
| 10. |
Fernandes Felix JP, Cavalcanti Lira RP, Grupenmacher AT, et al. Long-term results of trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrent Toxoplasma gondii retinochoroiditis[J]. Am J Ophthalmol, 2020, 213: 195-202. DOI: 10.1016/j.ajo.2019.12.025.
|
